Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesús Amo-Aparicio

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Neuroinflammation|June 13, 2019
BET protein inhibition regulates cytokine production and promotes neuroprotection after spinal cord injuryJudith Sánchez-Ventura, Jesús Amo-Aparicio, Xavier Navarro, et al.
Glia|July 30, 2016
IL-4 drives microglia and macrophages toward a phenotype conducive for tissue repair and functional recovery after spinal cord injuryIsaac Francos-Quijorna, Jesús Amo-Aparicio, Anna Martinez-Muriana, et al.
Current Protocols in Immunology|September 26, 2018
Neuroinflammation Quantification for Spinal Cord InjuryJesús Amo-Aparicio, Anna Martínez-Muriana, Alba Sánchez-Fernández, et al.
Brain, Behavior, and Immunity|June 6, 2018
CD200 modulates spinal cord injury neuroinflammation and outcome through CD200R1Natalia Lago, Bruno Pannunzio, Jesús Amo-Aparicio, et al.
Cells|June 10, 2022
CD200R1 Contributes to Successful Functional Reinnervation after a Sciatic Nerve InjuryBruno Pannunzio, Jesús Amo-Aparicio, Camila Julián, et al.
Theranostics|January 4, 2021
IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8Alba Sánchez-Fernández, Stephanie Zandee, Jesús Amo-Aparicio, et al.
Frontiers in Immunology|June 13, 2022
IL-38 Gene Deletion Worsens Murine ColitisDennis M de Graaf, Ruth X Wang, Jesús Amo-Aparicio, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2020
CD300f immunoreceptor is associated with major depressive disorder and decreased microglial metabolic fitnessNatalia Lago, Fernanda N Kaufmann, María Luciana Negro-Demontel, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Neuroinflammation|June 13, 2019
BET protein inhibition regulates cytokine production and promotes neuroprotection after spinal cord injuryJudith Sánchez-Ventura, Jesús Amo-Aparicio, Xavier Navarro, et al.
Glia|July 30, 2016
IL-4 drives microglia and macrophages toward a phenotype conducive for tissue repair and functional recovery after spinal cord injuryIsaac Francos-Quijorna, Jesús Amo-Aparicio, Anna Martinez-Muriana, et al.
Current Protocols in Immunology|September 26, 2018
Neuroinflammation Quantification for Spinal Cord InjuryJesús Amo-Aparicio, Anna Martínez-Muriana, Alba Sánchez-Fernández, et al.
Brain, Behavior, and Immunity|June 6, 2018
CD200 modulates spinal cord injury neuroinflammation and outcome through CD200R1Natalia Lago, Bruno Pannunzio, Jesús Amo-Aparicio, et al.
Cells|June 10, 2022
CD200R1 Contributes to Successful Functional Reinnervation after a Sciatic Nerve InjuryBruno Pannunzio, Jesús Amo-Aparicio, Camila Julián, et al.
Theranostics|January 4, 2021
IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8Alba Sánchez-Fernández, Stephanie Zandee, Jesús Amo-Aparicio, et al.
Frontiers in Immunology|June 13, 2022
IL-38 Gene Deletion Worsens Murine ColitisDennis M de Graaf, Ruth X Wang, Jesús Amo-Aparicio, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2020
CD300f immunoreceptor is associated with major depressive disorder and decreased microglial metabolic fitnessNatalia Lago, Fernanda N Kaufmann, María Luciana Negro-Demontel, et al.
Pageof 1